Exploring patient satisfaction with long-term warfarin for the treatment of atrial fibrillation.

被引：2
|
作者：
Murray, M
Wild, D
Reaney, M
机构：
[1] Bayer Plc, Global Hlth Econ & Reimbursement, Uxbridge, Middx, England
[2] Oxford Outcomes, Oxford, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.2245.2245
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2245
引用
收藏
页码：632A / 633A
页数：2
相关论文
共 50 条
  • [41] Patient preference and capabilities are at least as important as clinical contraindications as barriers to prescribing warfarin in patients with atrial fibrillation.
    Hollowell, J
    Ingelgard, A
    Reddy, P
    Gold, K
    Fitzmaurice, D
    BLOOD, 2004, 104 (11) : 606A - 606A
  • [42] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [43] Interventional occlusion of left atrial appendage in patients with atrial fibrillation. Acute and long-term outcome of occluder implantation in the LAARGE Registry
    Johannes Brachmann
    Thorsten Lewalter
    Ibrahim Akin
    Horst Sievert
    Volker Geist
    Uwe Zeymer
    Damir Erkapic
    Harald Mudra
    Sven Pleger
    Matthias Hochadel
    Jochen Senges
    Journal of Interventional Cardiac Electrophysiology, 2020, 58 : 273 - 280
  • [44] Long-Term Outcomes of Surgical Treatment for Atrial Fibrillation in a Complex Population
    Cesario, David A.
    Cunningham, Mark
    Baker, Craig
    Cohen, Robbin
    Lopez, Becky
    Starnes, Vaughn
    CIRCULATION, 2011, 124 (21)
  • [45] Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
    Korompoki, Eleni
    Filippidis, Filippos T.
    Nielsen, Peter B.
    Del Giudice, Angela
    Lip, Gregory Y. H.
    Kuramatsu, Joji B.
    Huttner, Hagen B.
    Fang, Jiming
    Schulman, Sam
    Marti-Fabregas, Joan
    Gathier, Celine S.
    Viswanathan, Anand
    Biffi, Alessandro
    Poli, Daniela
    Weimar, Christian
    Malzahn, Uwe
    Heuschmann, Peter
    Veltkamp, Roland
    NEUROLOGY, 2017, 89 (07) : 687 - 696
  • [46] Patient-Reported Treatment Satisfaction with Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study
    Hanon, Olivier
    Chaussade, Edouard
    Gueranger, Pierre
    Gruson, Elise
    Bonan, Sabrina
    Gay, Alain
    PLOS ONE, 2016, 11 (12):
  • [47] Interventional occlusion of left atrial appendage in patients with atrial fibrillation. Acute and long-term outcome of occluder implantation in the LAARGE Registry
    Brachmann, Johannes
    Lewalter, Thorsten
    Akin, Ibrahim
    Sievert, Horst
    Geist, Volker
    Zeymer, Uwe
    Erkapic, Damir
    Mudra, Harald
    Pleger, Sven
    Hochadel, Matthias
    Senges, Jochen
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2020, 58 (03) : 273 - 280
  • [48] Long-term anticoagulation in patients with atrial fibrillation
    Schuchert, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (13) : 681 - 684
  • [49] Long-term risk of death, stroke, or TIA and heart failure in patients with lone paroxysmal or persistent atrial fibrillation.
    Jahangir, A
    Lee, V
    Friedman, PA
    Hodge, DO
    Kopecky, SL
    Packer, DL
    Hammill, SC
    Shen, WK
    Gersh, BJ
    CIRCULATION, 2004, 110 (17) : 668 - 668
  • [50] Possible new treatment modality for atrial fibrillation.
    Agarawal, N.
    Fissha, M. Z.
    Baltazar, R.
    Cummings, C.
    Mower, M. M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (02) : S360 - S360
12345